2021
DOI: 10.21203/rs.3.rs-1021248/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The anti-tumor effect of stigmasterol on sorafenib treated human breast cancer cell lines

Abstract: Background: Breast cancer is the most common invasive malignancy and the leading cause of tumor-related death among women globally. Excessive angiogenesis, sustained proliferation, and evasion of apoptosis are crucial for breast cancer progression. Sorafenib is a multi-kinase receptor inhibitor with anti-angiogenic activity. Stigmasterol is a phytosterol with anticancer activity. The aim of this study was to investigate molecular mechanisms of action of sorafenib and stigmasterol in two different human breast … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…(Manral et al, 2016; Priya, Jha, Satish Kumar, & Sabarathinam, 2022; Verma et al, 2018). The NF‐κB signaling activation is regulated by tumor suppressor genes loss, such as von Hippel–Lindau tumor suppressor (VHL), tumor protein p53 (TP53), phosphatase, and tensin homolog (PTEN), and by the expression of some oncogenes, such as the BCR activator of RhoGEF and GTPase (BCR)/ABL proto‐oncogene 1 (Manral et al, 2016; Omran, Abd‐Alhaseeb, & Houssen, 2021).…”
Section: Novel Molecular Signaling Cascades and Cancer: Critical Role...mentioning
confidence: 99%
“…(Manral et al, 2016; Priya, Jha, Satish Kumar, & Sabarathinam, 2022; Verma et al, 2018). The NF‐κB signaling activation is regulated by tumor suppressor genes loss, such as von Hippel–Lindau tumor suppressor (VHL), tumor protein p53 (TP53), phosphatase, and tensin homolog (PTEN), and by the expression of some oncogenes, such as the BCR activator of RhoGEF and GTPase (BCR)/ABL proto‐oncogene 1 (Manral et al, 2016; Omran, Abd‐Alhaseeb, & Houssen, 2021).…”
Section: Novel Molecular Signaling Cascades and Cancer: Critical Role...mentioning
confidence: 99%
“…Studies have highlighted the synergistic anticancer effects that natural medicine monomers can exhibit when combined with chemotherapeutic drugs. For example, the influence of sigmasterol on sorafenib-treated human breast cancer cell lines [11] and the potential of rhamnazin to enhance the antitumour effects of sorafenib-treated human hepatocellular carcinoma (HCC) cell lines [12].…”
Section: Introductionmentioning
confidence: 99%